Signal active
Investment Firm
Overview
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.
Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.
Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Highlights
2006
Financial Services
51-100
960
517
78
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Qiming Venture Partners, established in 2006 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Social Media, Virtualization, Developer Platform, Financial Services, Venture Capital, Finance, Consumer, Health Care, Mobile, SaaS. The organization boasts a portfolio of 946 investments, with an average round size of $40.1M and 78 successful exits. Their recent investments include Nurien Software, New Enterprise Associates, Globespan Capital Partners, Kaixin001, Ceyuan Ventures. The highest investment round they participated in was $1783.3B. Among their most notable exits are Nurien Software and New Enterprise Associates. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
960
22
517
78
Investments
960
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 14, 2024 | AusperBio | Biotechnology | 37.0M |
Jul 30, 2024 | LTZ Therapeutics | Biotechnology | 20.0M |
Aug 06, 2024 | Dr.Clear Aligner | Health Care | 14.0M |
Aug 07, 2024 | - | - | 2.8M |
Exits
78
Funding Timeline
960
0
18
Funding Rounds
960
Qiming Venture Partners has raised 960 rounds. Their latest funding was raised on Aug 07, 2024 from a Seed Round - Chenzhang Biotechnology round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 14, 2024 | Series A - AusperBio | - | 37.0M | - |
Jul 30, 2024 | Series A - LTZ Therapeutics | - | 20.0M | - |
Aug 06, 2024 | Series A - Dr.Clear Aligner | - | 14.0M | - |
Aug 07, 2024 | Seed Round - Chenzhang Biotechnology | - | 2.8M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.